基于网络药理学的芡实-金樱子药对治疗糖尿病肾病的分子机制研究

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (2006 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the molecular mechanism of Semen Euryales-Fructus Rosae Laevigatae in the treatment of diabetic nephropathy (DN) based on network pharmacology. Methods The drug ingredients and targets were investigated by traditional Chinese medicine systems pharmacology database and analysis platform, encyclopaedia of traditional Chinese medicine, and Swiss Target Prediction databases, and the GeneCards and OMIM databases were searched for targets related to DN. The protein-protein interaction network and drug-target network were constructed by STRING platform and Cytoscape software, and network topology analysis and core target screening were completed. The enrichment analyses of gene ontology and Kyoto Encyclopedia of Genes and Genomes were completed by R software, and the core pathways and targets were obtained. Finally, the molecular docking of core ingredient targets was completed by VINA software. Results Two active ingredients of Semen Euryales, and seven active ingredients of Fructus Rosae Laevigatae were obtained, including quercetin, kaempferol, gondoic acid, and other core active ingredients. The 20 core targets including mitogen activated protein kinase (MAPK) 1, and transcription factor-AP1 (Jun), MAPK3 were screened. Gene ontology enrichment analysis showed that the targets were mainly concentrated in the cell membrane region, which played various biological functions including cell signal transduction and nuclear transcription, and completed multiple regulatory response to lipopolysaccharide and oxidative stress. Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that the main enrichment pathways were the AGE-RAGE, MAPK, PI3k-Akt, NF-κB, and other signaling pathways. The results of molecular docking showed that quercetin and kaempferol had good affinity with core targets, such as MAPK1, transcription factor-AP1 (Jun) and so on. Conclusion This study applies the network pharmacology method to elucidate the possible mechanism of Semen Euryales-Fructus Rosae Laevigatae pairs in the treatment of DN, including multiple pathways and targets to regulate the complex inflammatory response and oxidative stress, which provides clues and basis for further experimental and clinical pharmacological studies.

Key words： Semen Euryales Fructus Rosae Laevigatae Network pharmacology Diabetic nephropathy Molecular docking

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Xiaoran1 WANG Xueying2 ZHANG Hua1 WANG Shidong1 ZHENG Xiaoyan1

Cite this article:

LI Xiaoran1 WANG Xueying2 ZHANG Hua1 WANG Shidong1 ZHENG Xiaoyan1. Molecular mechanism exploration of Semen Euryales-Fructus Rosae Laevigatae in the treatment of diabetic nephropathy based on network pharmacology#br#[J]. 中国医药导报, 2021, 18(36): 34-39.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I36/34

[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中国实用内科杂志，2018，38（4）：53.
[2] Colhoun HM，Marcovecchio ML. Biomarkers of diabetic kidney disease [J]. Diabetologia，2018，61（5）：996-1011.
[3] 中华中医药学会.糖尿病肾病中医防治指南[J].中国中医药现代远程教育，2011，9（4）：151-153.
[4] 肖永华.吕仁和治疗糖尿病肾病经验[J].世界中医药，2007（3）：151-153.
[5] 刘美奇，尹科美.吕仁和教授治疗糖尿病肾病4期蛋白尿的方法[J].北京中医药大学学报：中医临床版，2003（4）：26.
[6] 王宇光，张琪.国医大师张琪从脾肾论治肾病蛋白尿经验[J].湖南中医药大学学报，2017，37（9）：925-927.
[7] Sanajou D，Ghorbani Haghjo A，Argani H，et al. AGE-RAGE axis blockade in diabetic nephropathy：Current status and future directions [J]. Eur J Pharmacol，2018，833：158-164.
[8] Warren AM，Knudsen ST，Cooper ME. Diabetic nephropathy：an insight into molecular mechanisms and emerging therapies [J]. Expert Opin Ther Targets，2019，23（7）：579-591.
[9] 桑小溪.糖尿病肾病发病机制的研究进展[J].当代医学，2019，25（17）：193-194.
[10] 蔡晟宇.水陆二仙丹防治糖尿病肾病的研究概述[J].中国处方药，2019，17（12）：17-18.
[11] Dehdashtian E，Pourhanifeh MH，Hemati K，et al. Therapeutic application of nutraceuticals in diabetic nephropathy：Current evidence and future implications [J]. Diabetes Metab Res Rev，2020，36（8）：e3336.
[12] 朱开梅，唐丽霞，赵文鹏，等.槲皮素脂质体对糖尿病肾病氧化应激和TGF-β1/Smad7通路的影响[J].安徽医科大学学报，2017，52（3）：319-323.
[13] 汤利华，方超，王浩然，等.山奈酚对高糖诱导的糖尿病肾病大鼠肾功能和组织病理损伤的保护作用[J].免疫学杂志，2018，34（12）：1041-1046.
[14] Xu Q，Prabhu A，Xu S，et al. Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney [J]. Am J Physiol Renal Physiol，2009，297（2）：F307-F315.
[15] Winklhofer-Roob BM，Rock E，Ribalta J，et al. Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies [J]. Mol Aspects Med，2003，24（6）：391-402.
[16] 杨超茅，杨志新，马晓玲.AGEs-RAGE信号通路在糖尿病肾病中的作用机制及中医药研究进展[J].中医学报，2019，34（9）：1864-1868.
[17] Sifuentes-Franco S，Padilla-Tejeda DE，Carrillo-Ibarra S，et al. Oxidative Stress，Apoptosis，and Mitochondrial Function in Diabetic Nephropathy [J]. Int J Endocrinol，2018，2018：1875870.
[18] 梁泽智，祝胜郎.p38MAPK及其在糖尿病肾病中的作用研究进展[J].医学综述，2015，21（19）：3542-3544.
[19] Rogacka D，Piwkowska A，Audzeyenka I，et al. Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes [J]. Int J Biochem Cell Biol，2014，51：120-130.
[20] 张翠香，洪晓华，侯金才，等.链脲佐菌素糖尿病肾病大鼠模型肾小球损伤的机制[J].中华中医药杂志，2015， 30（9）：3087-3091.
[21] 童楠，张宁.中药益肾颗粒通过PI3k/Akt/mTOR和LKB1/AMPK/Sirt1信号通路对糖尿病肾病大鼠的干预作用研究[J].中华中医药杂志，2018，33（5）：1853-1857.
[22] Tang S，Yiu WH. Innate immunity in diabetic kidney disease [J]. Nat Rev Nephrol，2020，16（4）：206-222.
[23] Chow FY，Nikolic-Paterson DJ，Ma FY，et al. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice [J]. Diabetologia，2007，50（2）：471-480.
[24] 张宁.NF-κB调控下OPN、MCP-1在糖尿病肾病患者血清中的表达及临床意义[D].锦州：辽宁医学院，2012.
[25] 孙文佳，闵伟红，邱斌，等.NF-κB信号通路与糖尿病肾病治疗研究进展[J].现代生物医学进展，2016，16（18）：3422，3589-3592.